ArticleCureus2025
Critical Connections: Diagnosis of Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma-Associated Hemophagocytic Lymphohistiocytosis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hemophagocytic lymphohistiocytosis (HLH) is a rare and potentially fatal condition associated with Epstein-Barr virus (EBV) in children and adults. We report a case of a 65-year-old male with a history of EBV-positive nasopharyngeal carcinoma in remission presenting with fever, altered mental status, abdominal pain, and generalized weakness. Labs showed pancytopenia, hyponatremia, hypochloremia, acute-on-chronic kidney injury, and hypoalbuminemia. The patient was started on empiric broad-spectrum antimicrobials, intravenous crystalloids, and red blood cell transfusions. HLH was suspected, and laboratory evaluation demonstrated elevated EBV viral load, ferritin, and soluble interleukin-2 receptor levels. He met diagnostic criteria for HLH and was started on etoposide and methylprednisolone. However, due to rapid deterioration, the family requested hospice care, and the patient passed away four days later. This case highlights severe presentations of HLH and the importance of considering HLH in the differential diagnosis of patients with nasopharyngeal carcinoma presenting with undifferentiated multisystem syndromes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.